Athena Athena

X

Find the latest Drugs in Development and Pipeline Prospector News of Forbius.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Forbius
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
701 Brazos Street, Suite 930 Austin, Texas 78701
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Pursuant to the terms of the transaction, Forbius’ non-TGF-beta assets were transferred to a newly formed private company which is being retained by Forbius’ existing shareholders.


Lead Product(s): AVID200

Therapeutic Area: Oncology Product Name: AVID200

Highest Development Status: Phase IProduct Type: Large molecule

Partner/Sponsor/Collaborator: Bristol Myers Squibb

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition September 21, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Details:

Under this transaction, Bristol Myers Squibb would acquire Forbius’s TGF-beta program, including the program’s lead investigational asset, AVID200. TGF-beta is a key cytokine that regulates various cell processes, including regulation of the immune system.


Lead Product(s): AVID200

Therapeutic Area: Oncology Product Name: AVID200

Highest Development Status: Phase IProduct Type: Large molecule

Partner/Sponsor/Collaborator: Bristol Myers Squibb

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition August 24, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY